Radico Khaitan Employee Stock Options

Radico Khaitan ED Probe / Tax Survey

Radico Khaitan disclosed that DRI officials visited its New Delhi office and Rampur plant on October 26, 2026, under the Customs Act. The company reports no current financial or operational impact and is cooperating fully.

Radico Khaitan Management Change

Radico Khaitan appoints CFO Dilip Kumar Banthiya as Executive Director effective October 28, 2026. Saket Somani is elevated to Deputy Chief Financial Officer.

Radico Khaitan Q2 FY27 Results: Net Profit ₹232.3 Cr, Up 66.4% YoY

Radico Khaitan Ltd reported revenue from operations of ₹5,583 Cr (+10.4% YoY) and net profit of ₹232.3 Cr (+66.4% YoY) for Q2 FY27.

Key figure

Net profit ₹232.3 Cr · +66.4% YoY

Radico Khaitan Other Announcement

Radico Khaitan Limited received an ESG rating score of 69 from NSE Sustainability Ratings and Analytics Limited. This unsolicited rating was based on the company's independent public disclosures.

Radico Khaitan Earnings Call Transcript: Key Takeaways

Radico reports a record quarter led by premiumization, with the P&A segment delivering a staggering 36% volume growth.

Call

Guides 25% growth

Radico Khaitan Board Meeting Date

Radico Khaitan Ltd will hold a board meeting on October 27, 2026, to approve the financial results for the quarter and half year ended September 30, 2026.

Aye Finance Employee Stock Options

Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.

Aarti Pharmalabs Employee Stock Options

Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.

OnEMI Technology Solutions Employee Stock Options

OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.

Bliss GVS Pharma Employee Stock Options

Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.

Bandhan Bank Employee Stock Options

Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.

Maxvolt Energy Industries Employee Stock Options

Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.

Execution

Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date